Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
University of Florida
City of Hope Medical Center
Institut Curie
Brigham and Women's Hospital
Travera Inc
Washington University School of Medicine
Sichuan Enray Pharmaceutical Sciences Company
University of Alabama at Birmingham
Instituto do Cancer do Estado de São Paulo
Tempus AI